Status:
COMPLETED
Transcranial Magnetic Stimulation for Depression in Autism Spectrum Conditions
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Conditions:
Autism Spectrum Disorder
Major Depressive Disorder
Eligibility:
All Genders
12-26 years
Phase:
NA
Brief Summary
In this research study the investigators aim to learn more about the therapeutic effects of a newer form of non-invasive transcranial magnetic stimulation (TMS), called theta burst simulation (TBS), o...
Detailed Description
The overarching goal of this study is to examine treatment effects and elucidate the physiological biomarkers of a newer form of non-invasive brain stimulation therapy on refractory depression in a sa...
Eligibility Criteria
Inclusion
- Have been diagnosed on the autism spectrum
- Have been diagnosed with depression and have failed one or more evidence-based antidepressant treatments (e.g. a Selective Serotonin Reuptake Inhibitor, talk therapy like Cognitive Behavioral Therapy)
- Do not have an intellectual disability
Exclusion
- Substance use disorder
- Presence of metallic foreign bodies or implanted medical devices
- History of epilepsy
- Prior rTMS treatment
- For female subjects of child bearing potential, current pregnancy
Key Trial Info
Start Date :
November 24 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 23 2023
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT05271357
Start Date
November 24 2021
End Date
February 23 2023
Last Update
February 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229